** Shares in DocMorris DOCM.S slump 12.6% after the Swiss
online drug retailer cut its yearly outlook, as it released full
H1 results
** DocMorris expects annual adj. EBITDA loss of around CHF
50 mln ($58 mln), vs previous forecast of between 0 and minus
CHF 35 mln, and an increase in external revenue of 5-10%, vs
more than 10% previously
** "Whilst the reduced bottom-line guidance (CHF -50m) was
largely expected, we consider the lower revenue target (5-10%)
the biggest negative surprise," Jefferies ("buy") writes
($1 = 0.8615 Swiss francs)
(Reporting by Tristan Veyet)
((Tristan.chabba@thomsonreuters.com))